The human microbiome and kidney diseases in children

Česká verzia

Authors: J. Krajčír ¹; B. Piteková ¹; M. Chromek ²; Ľ. Podracká ¹
Authors place of work: Detská klinika, Národný ústav detských chorôb a Lekárska fakulta Univerzity Komenského, Bratislava, Slovensko ¹; Jednotka detskej nefrológie, Detská nemocnica Astrid Lindgrenovej, Karolínska univerzitná nemocnica a Karolinska Inštitút, Štokholm, Švédsko ²
Published in the journal: Čes-slov Pediat 2021; 76 (7): 382-391.
Category: Review

Summary

The microbiome is a complex structure consisting of all bacteria, viruses, fungi and other microorganisms which colonize the surfaces and mucous membranes of the human body. There exists a specific and symbiotic relationship between the microbiome and the human body, both sides can benefit greatly from this relationship. Alterations of the normal microbiome composition can lead to various pathological conditions. The kidneys and gut micriobiome both produce several molecules which can regulate each other’s function in a positive or negative way. Are human urine and the mucous membranes of our urinary tract really sterile as suggested by the Human Microbiome project? Is it possible that there is a connection between the composition of the intestinal microbiome and the development of urinary tract infections in children? The therapy using fecal microbial transplantation has great results in patients with Clostridium difficile gut infections, but can it regulate the course of urinary tract infections in humans, too?

Keywords:

Urinary tract infections – gut microbiome – urobiome – colorenal axis

Zdroje

1. Rabb H, Pluznick J, Noel S. The microbiome and acute kidney injury. Nephron 2018; 140 (2): 120–123.

2. Jagodzinski A, Zielinska E, Laczmanski L, Hirnle L. The early years of life. Are they influenced by our microbiome? Ginekol Pol 2019; 90 (4): 228–232.

3. Young VB. The role of the microbiome in human health and disease: an introduction for clinicians. BMJ 2017; 356: j831.

4. Tanaka M, Nakayama J. Development of the gut microbiota in infancy and its impact on health in later life. Allergol Int 2017; 66 (4): 515–522.

5. Collado MC, Rautava S, Aakko J, et al. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep 2016 Mar 22; 6: 23129.

6. Vasylyeva TL, Singh R. Gut microbiome and kidney disease in pediatrics: does connection exist? Front Microbiol 2016; 7: 235.

7. Gong J, Noel S, Pluznick JL, et al. Gut microbiota-kidney crosstalk in acute kidney injury. Semin Nephrol 2019; 39 (1): 107–116.

8. Andrade-Oliveira V, Amano MT, Correa-Costa M, et al. Gut bacteria products prevent AKI induced by ischemia-reperfusion. J Am Soc Nephrol 2015; 26 (8): 1877–1888.

9. Schauber J, Svanholm C, Termén S, et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 2003 May; 52 (5): 735–441.

10. Natarajan N, Hori D, Flavahan S, et al. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiol Genomics 2016; 48 (11): 826–834.

11. Pluznick JL, Protzko RJ, Gevorgyan H, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A 2013; 110 (11): 4410–4415.

12. Satoh M, Hayashi H, Watanabe M, et al. Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure. Nephron Exp Nephrol 2003; 95 (3): e111–e118.

13. Denburg MR, Koepsell K, Lee JJ, et al. Perturbations of the gut microbiome and metabolome in children with calcium oxalate kidney stone disease. J Am Soc Nephrol 2020 Jun; 31 (6): 1358–1369.

14. Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int 2013 Jun; 83 (6): 1010–1016.

15. Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int 2013; 83 (2): 308–315.

16. Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 2014; 25 (4): 657–670.

17. Crespo-Salgado J, Vehaskari VM, Stewart T, et al. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study. Microbiome 2016; 4: 50.

18. Crespo-Salgado J, Stewart T, Aviles DH. Does dysbiosis in intestinal microbiome plays a role in children with relapsing idiopathic nephrotic syndrome? Am J Nephrol 2018; 47 (3): 162–163.

19. Kang Y, Feng D, Law HK, et al. Compositional alterations of gut microbiota in children with primary nephrotic syndrome after initial therapy. BMC Nephrol 2019; 20: 434.

20. Tsuji S, Suruda C, Hashiyada M, et al. Gut microbiota dysbiosis in children with relapsing idiopathic nephrotic syndrome. Am J Nephrol 2018; 47: 164–170.

21. Wilck N, Matus MG, Kearney SM, et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature 2017; 551 (7682): 585–589.

22. Jones-Freeman B, Chonwerawong M, Marcelino VR, et al. The microbiome and host mucosal interactions in urinary tract diseases. Mucosal Immunol 2021; 14: 779–792. https://doi.org/10.1038/ s41385-020-00372-5.

23. Magistro G, Stief CG. The urinary tract microbiome: the answer to all our open questions? Eur Urol Focus 2019 Jan; 5 (1): 36–38.

24. Lee KW, Song HY, Kim YH. The microbiome in urological diseases. Investig Clin Urol 2020; 61 (4): 338–348.

25. Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, et al. The urinary tract microbiome in health and disease. Eur Urol Focus 2018 Jan; 4 (1): 128–138.

26. Kinneman L, Zhu W, Wong WSW, et al. Assessment of the urinary microbiome in children younger than 48 months. Pediatr Infect Dis J 2020 Jul; 39 (7): 565–570.

27. Gerber D, Forster CS, Hsieh M. The role of the genitourinary microbiome in pediatric urology: a review. Curr Urol Rep 2018; 19 (1): 13.

28. Siddiqui H, Nederbragt AJ, Lagesen K, et al. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol 2011; 11: 244.

29. Piteková B, Podracká Ľ. Črevná mikrobiota a infekcie močových ciest u detí. Lek Obz 2020, 69 (10): 339–340.

30. Paalanne N, Husso A, Salo J, Pieviläinen O, et al. Intestinal microbiome as a risk factor for urinary tract infections in children. Eur J Clin Microbiol Infect Dis 2018 Oct; 37 (10): 1881–1891.

31. Magruder M, Sholi AN, Gong C, et al. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun 2019 Dec 4; 10 (1): 5521.

32. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015; 13 (5): 269–284.

33. Iannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr 2010; 29 (6): 701–725.

34. Chromek M, Slamová Z, Bergman P, et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 2006 Jun; 12 (6): 636–641.

35. Tariq R, Pardi DS, Tosh PK, et al. Fecal microbiota transplantation for recurrent Clostridium difficile infection reduces recurrent urinary tract infection frequency. Clin Infect Dis 2017 Oct 30; 65 (10): 1745–1747.

36. Wullt B, Svanborg C. Deliberate establishment of asymptomatic bacteriuria – A novel strategy to prevent recurrent UTI. Pathogens 2016; 5 (3): 52.

37. Sun J, Marais JP, Khoo C, et al. Cranberry (Vaccinium macrocarpon) oligosaccharides decrease biofilm formation by uropathogenic Escherichia coli. J Funct Foods 2015; 17: 235–242.

38. Hisano M, Bruschini H, Nicodemo AC, Srougi M. Cranberries and lower urinary tract infection prevention. Clinics (Sao Paulo) 2012; 67 (6): 661–668.

39. Uptodate.com (2021).